Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitesavarapharma.com
CategoryBioTech
Phone512-961-1891
Emailinfo@savarapharma...
Employees
Founded2007
Descriptioninhalation drug delivery platform

Offices

Austin, USA
3925 West Braker Lane
Austin, TX, 78759
USA

People

CEO , President & Founder
Founder & Head of Product Development
Founder & Head of Business Operations
Board of Directors
Board of Directors
Director
Director
Director of Quality
Show All People

Funding

TOTAL $31.5M
FUNDING TOTAL $31.5M
Series A, 7/2009
$833k
Partial Close, 12/2009
$656k
Venture Round, 3/2010
$1.42M
Series B, 6/2012
$6.9M
Series B, 3/2013
Tech Coast Angels
Keiretsu Forum
Central Texas Angel Network
North Texas Angel Network
$7.4M
Series B, 6/2013
$14.3M

Tags

Savara Pharmaceuticals

Savara Pharmaceuticals develops next generation pulmonary drug delivery solutions using its NanoCluster formulation technology. Dry powder and nebulizer-based medicines are formulated directly from active drug ingredients, requiring no carrier particles and little or no excipients. The aerodynamics of NanoCluster formulations are fully customizable from one to seven microns enabling high drug concentrations at specific regions of the lung, independent of the rate or depth of breath. Savara expects that NanoCluster’s unique features will produce numerous patient benefits including reduced dosage, enhanced efficacy, improved safety and increased tolerability, as well as greater patient convenience. Savara’s NanoCluster technology is currently available for evaluation and licensing.

Recent Milestones

Videos

Screenshots

Savara Pharmaceuticals screenshot
Above: Savara Pharmaceuticals
Uploaded: 10/24/09

Sources

  1. Savara Pharmaceuticals, Inc.: Series A $1.0M (onbiovc.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. Savara Pharmaceuticals Closes $7.4M Second Tranche of Series B Financing (finsmes.com) [edit]
  6. Savara updates Series B funding tranche to $14.3M (bizjournals.com) [edit]
Edit This Page
Last Edited 3/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy